ProfileGDS4718 / 232887_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 52% 56% 85% 59% 57% 53% 56% 58% 59% 59% 56% 63% 53% 48% 55% 59% 55% 53% 51% 52% 56% 57% 56% 61% 58% 51% 57% 55% 55% 55% 56% 59% 58% 57% 55% 52% 55% 59% 57% 84% 59% 53% 59% 50% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.6426952
GSM549102patient 115, normal, homogenized [OPG study]5.8694156
GSM549104patient 119, normal, homogenized [OPG study]8.585385
GSM549108patient 138, normal, homogenized [OPG study]6.1044359
GSM549119patient 077, normal, homogenized [OPG study]5.9171857
GSM549133patient 032, cancer, homogenized [OPG study]5.6652553
GSM549139patient 042, cancer, homogenized [OPG study]5.8473356
GSM549099patient 107, normal, homogenized [OPG study]5.9777758
GSM549109patient 139, normal, homogenized [OPG study]6.1041959
GSM549110patient 046, normal, homogenized [OPG study]6.0382559
GSM549114patient 063, normal, homogenized [OPG study]5.8180356
GSM549122patient 082, normal, homogenized [OPG study]6.3636863
GSM549134patient 033, cancer, homogenized [OPG study]5.673153
GSM549136patient 036, cancer, homogenized [OPG study]5.3620348
GSM549140patient 044, cancer, homogenized [OPG study]5.7570655
GSM549111patient 047, normal, homogenized [OPG study]6.093259
GSM549113patient 057, normal, homogenized [OPG study]5.7771555
GSM549132patient 031, cancer, homogenized [OPG study]5.6853953
GSM549137patient 038, cancer, homogenized [OPG study]5.5488151
GSM549142patient 047, cancer, homogenized [OPG study]5.7385452
GSM549100patient 110, normal, homogenized [OPG study]5.8434556
GSM549107patient 135, normal, homogenized [OPG study]5.8854757
GSM549115patient 068, normal, homogenized [OPG study]5.8192756
GSM549116patient 072, normal, homogenized [OPG study]6.1758861
GSM549120patient 078, normal, homogenized [OPG study]5.9989358
GSM549131patient 030, cancer, homogenized [OPG study]5.5296251
GSM549118patient 074, normal, homogenized [OPG study]5.9354257
GSM549129patient 027, cancer, homogenized [OPG study]5.801555
GSM549123patient 088, normal, homogenized [OPG study]5.8020355
GSM549124patient 006, cancer, homogenized [OPG study]5.8451255
GSM549126patient 015, cancer, homogenized [OPG study]5.8479856
GSM549128patient 025, cancer, homogenized [OPG study]6.0603259
GSM549103patient 117, normal, homogenized [OPG study]5.9865558
GSM549117patient 073, normal, homogenized [OPG study]5.8923857
GSM549138patient 041, cancer, homogenized [OPG study]5.8337955
GSM549141patient 045, cancer, homogenized [OPG study]5.5729152
GSM549130patient 028, cancer, homogenized [OPG study]5.7898355
GSM549101patient 111, normal, homogenized [OPG study]6.1052259
GSM549105patient 128, normal, homogenized [OPG study]5.9554357
GSM549106patient 134, normal, homogenized [OPG study]8.4862584
GSM549112patient 048, normal, homogenized [OPG study]6.0273259
GSM549125patient 011, cancer, homogenized [OPG study]5.6966853
GSM549127patient 024, cancer, homogenized [OPG study]6.1145659
GSM549135patient 035, cancer, homogenized [OPG study]5.5044750